Olive Oil and Cardiovascular Risk: The Higher the Consumption, the Lower the Risk?

High olive oil intake was associated with lower risk of coronary heart disease and cardiovascular disease in two large prospective cohorts of men and women.

Aceite de oliva y riesgo cardiovascular ¿A mayor consumo menos enfermedad?

The substitution of margarine, butter, mayonnaise, and dairy fat with olive oil can have a significant impact on cardiovascular health.

The benefits of olive oil intake have been well studied in Mediterranean populations. However, two factors should be considered: first, besides olive oil, that population consumes a whole combination of foods with cardiovascular benefit (a Mediterranean diet); second, the Mediterranean region is the main producer of olive oil and many feared a conflict of interests.

In that sense, we wondered about the effectiveness of this product in populations in other corners of the world.


Read also: Is There a “Safe” Dose for Meat Consumption?


This study assessed the eventual benefit of olive oil intake as regards overall cardiovascular disease, coronary heart disease, and stroke risk in an American population.

This study included 61,181 women and 31,797 men from 1990 to 2014 who were free of cancer, heart disease, and stroke at baseline. Diet was assessed through questionnaires at baseline and then every 4 years.

After 24 years of follow-up, adjusting for other risk factors, high olive oil intake (>0.5 tablespoon/day or >7 g/day) reduced the overall cardiovascular risk by 14% (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.79 to 0.94) and the coronary heart disease risk by 18% (HR: 0.82; 95% CI: 0.73 to 0.91), while there were no significant associations for total or ischemic stroke.


Read also: ACC Recommendations against the New Coronavirus.


Replacing 5 g/day of margarine, butter, mayonnaise, or dairy fat with the equivalent amount of olive oil reduces the total cardiovascular risk and the coronary heart disease risk by 5% to 7%.

The subset of participants with higher olive oil intake showed lower levels of circulating inflammatory biomarkers and a better lipid profile.

Conclusion

High olive oil intake was associated with a reduction in the risk of total cardiovascular and coronary heart disease. The substitution of margarine, butter, mayonnaise, and dairy fat with olive oil can have a clear benefit for cardiovascular health.

Título original: Olive Oil Consumption and Cardiovascular Risk in U.S. Adults.

Referencia: Marta Guasch-Ferré et al. Journal of the American College of Cardiology 2020, Journal Pre-proof. https://doi.org/10.1016/j.jacc.2020.02.036.


[wysija_form id=”3″]

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...